Who are Dosage of Calcium edetate de sodium's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dosage-of-calcium-edetate-de-sodium.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Dosage of Calcium edetate de sodium — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dosage of Calcium edetate de sodium (Dosage of Calcium edetate de sodium) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Heavy metal chelating agent. Area: Toxicology.

phase 3 Heavy metal chelating agent Lead and other heavy metal ions (Pb²⁺, Cd²⁺, Zn²⁺) Toxicology Small molecule Live · refreshed every 30 min

Target snapshot

Dosage of Calcium edetate de sodium (Dosage of Calcium edetate de sodium) — University Hospital, Limoges. Sodium calcium edetate is a chelating agent that binds and removes heavy metals (particularly lead) from the body by forming stable complexes that are excreted in urine.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Dosage of Calcium edetate de sodium TARGET	Dosage of Calcium edetate de sodium	University Hospital, Limoges	phase 3	Heavy metal chelating agent	Lead and other heavy metal ions (Pb²⁺, Cd²⁺, Zn²⁺)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Heavy metal chelating agent class)

University Hospital, Limoges · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dosage of Calcium edetate de sodium — Competitive Intelligence Brief. https://druglandscape.com/ci/dosage-of-calcium-edetate-de-sodium. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab